Registered number
06384162
PHARMA REGULATORY SERVICES LIMITED
Filleted Accounts
31 March 2024
PHARMA REGULATORY SERVICES LIMITED
Registered number: 06384162
Balance Sheet
as at 31 March 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 3 137 624
Investments 4 200,000 371,328
200,137 371,952
Current assets
Cash at bank and in hand 333,493 160,363
Creditors: amounts falling due within one year 5 (570) (1,195)
Net current assets 332,923 159,168
Total assets less current liabilities 533,060 531,120
Provisions for liabilities (6,374) (6,374)
Net assets 526,686 524,746
Capital and reserves
Called up share capital 2 2
Profit and loss account 526,684 524,744
Shareholders' funds 526,686 524,746
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mrs M Essaji
Director
Approved by the board on 7 August 2024
PHARMA REGULATORY SERVICES LIMITED
Notes to the Accounts
for the year ended 31 March 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery 25% straight line
Investment property
Investment property is included in the balance sheet at fair value. Net gains and losses from the fair value adjustments are recognised in the profit and loss account. Deferred taxation is provided on these gains at the rate expected to apply when the property is sold.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 1 2
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2023 5,592
At 31 March 2024 5,592
Depreciation
At 1 April 2023 4,968
Charge for the year 487
At 31 March 2024 5,455
Net book value
At 31 March 2024 137
At 31 March 2023 624
4 Investment property
2024
£
Fair value
At 1 April 2023 371,328
Disposals (171,328)
At 31 March 2024 200,000
Historical cost
At 1 April 2023 339,458
At 31 March 2024 168,130
During the year after disposal of an investment property, the valuation of the remaining investment property has remained the same at a fair value of £200,000. The valuation was made on an open market value basis by reference to market evidence of transaction prices of similar properties.
5 Creditors: amounts falling due within one year 2024 2023
£ £
Taxation and social security costs 570 1,196
Other creditors - (1)
570 1,195
6 Other information
PHARMA REGULATORY SERVICES LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
74 The Chase
Ickenham
Uxbridge
Middlesex
UB10 8ST
PHARMA REGULATORY SERVICES LIMITED 06384162 false 2023-04-01 2024-03-31 2024-03-31 VT Final Accounts April 2024 Mrs M Essaji No description of principal activity 06384162 2022-04-01 2023-03-31 06384162 core:WithinOneYear 2023-03-31 06384162 core:ShareCapital 2023-03-31 06384162 core:RetainedEarningsAccumulatedLosses 2023-03-31 06384162 2023-04-01 2024-03-31 06384162 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 06384162 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 06384162 bus:Director40 2023-04-01 2024-03-31 06384162 1 2023-04-01 2024-03-31 06384162 2 2023-04-01 2024-03-31 06384162 core:PlantMachinery 2023-04-01 2024-03-31 06384162 countries:England 2023-04-01 2024-03-31 06384162 bus:FRS102 2023-04-01 2024-03-31 06384162 bus:FilletedAccounts 2023-04-01 2024-03-31 06384162 2024-03-31 06384162 core:WithinOneYear 2024-03-31 06384162 core:ShareCapital 2024-03-31 06384162 core:RetainedEarningsAccumulatedLosses 2024-03-31 06384162 core:PlantMachinery 2024-03-31 06384162 core:DisposalsRepaymentsInvestments 2024-03-31 06384162 2023-03-31 06384162 core:PlantMachinery 2023-03-31 iso4217:GBP xbrli:pure